It’s a familiar scenario. You hear about a discovery that could lead to the cure for this disease or that debilitating condition. Then you never hear about it again.
That’s because the transition from discovery to clinical application or patient use can be difficult, lengthy and expensive. That, though, is the space we command and that is why clients find so much value in the entrepreneurial support – beyond funding – we bring to the portfolio companies we choose to partner with.
Those companies receive a wealth of experience, from business development and management expertise, to a solid understanding of technology transfer and how universities work, to connections to appropriate resources.
Be sure to review the information and tools found on our Entrepreneur Support page.